Key result
VAD unloading is linked to ~98% lower cardiac leptin production in failing human hearts.
Why the study?
Increased circulating leptin is present in human heart failure, but the changes in cardiac leptin production and signaling and the effect of mechanical unloading are not well characterized.
Does mechanical unloading with a VAD reduce leptin expression and signaling in the failing human heart?
Observational
Does mechanical unloading with a VAD reduce leptin expression and signaling in the failing human heart?
The failing human heart exhibits increased leptin expression and signaling, which is significantly downregulated by mechanical unloading with a VAD, suggesting a cardioprotective role for leptin via STAT3 and AMPK pathways.
Answers are grounded in this paper and cite their sources.
VAD unloading markedly reduces cardiac leptin expression in HF; hypothesis-generating for its role in reverse remodeling.
Background— Increased circulating leptin is present in human heart failure, and leptin deficiency is linked to worse outcomes in chronic ischemic injury. In the present observational study, we tested the hypothesis that cardiac leptin production and signaling are increased in the failing human heart, and that mechanical unloading with a ventricular assist device (VAD) reverses these changes. Methods and Results— All studies were performed using human cardiac tissue obtained from (1) hearts not matched for transplantation (nonfailing), (2) at the time of cardiac transplant (failing), or (3) paired samples at the time of VAD implant (pre-VAD) and removal (post-VAD). The expression of brain naturetic peptide, leptin, leptin receptor, and tumor necrosis factor α mRNA was measured, and the protein expression of leptin and its receptor was examined by Western blot and immunofluorescent staining of cardiac sections. The assessment of leptin signaling was performed by measuring the phosphorylation state of the leptin receptor. The phosphorylation state of signal transducer and activator of transcription-3 and AMP-activated kinase proteins were also measured. All data are expressed as mean�SEM with a statistical significance in failing relative to nonfailing groups determined by Student independent t test, and the significance between pre- and post-VAD groups determined by paired t test. In failing human hearts, the mRNA expressions of leptin and its receptor were increased 5.4�0.3-fold ( P <0.05) and 4.5�0.3-fold ( P <0.05), respectively, with similar changes in protein. The phosphorylation state of both the leptin receptor and signal transducer and activator of transcription-3 proteins were increased 1.4�0.1-fold ( P <0.05), and the level of phosphorylated AMP-activated kinase protein was increased 1.9�0.2-fold ( P <0.05). Mechanical unloading of the failing human heart with a VAD resulted in no change in tumor necrosis factor α expression but a marked decrease in leptin production to 1.7�0.1% ( P <0.05) and leptin receptor expression to 3.0�0.2% ( P <0.05) of pre-VAD levels. Phosphorylation of the leptin receptor, signal transducer and activator of transcription-3, and AMP-activated kinase were also decreased to 45�7%, 75�8%, and 58�8% of pre-VAD values, respectively ( P <0.05 for all values). Conclusions— These results indicate that the failing human heart increases expression of leptin and its receptor and that mechanical unloading downregulates this increase. Further, a cardioprotective role for leptin in the failing human heart is suggested through the activation of signal transducer and activator of transcription-3 and AMP-activated kinase signaling.
No takes yet. Share an insight, caveat, or question.
McGaffin et al. (2009) conducted an observational in Heart failure. Mechanical unloading with a ventricular assist device (VAD) vs. Pre-VAD failing heart (and nonfailing controls) was evaluated on Cardiac expression of leptin, leptin receptor, and phosphorylation states (p=<0.05). Mechanical unloading of the failing human heart with a ventricular assist device decreased leptin production to 1.7% and leptin receptor expression to 3.0% of pre-VAD levels.
Synapse has enriched 10 related papers. Consider them for comparative context: